short acting glp 1 agonists GLP-1 and Diabetes Mellitus Short‐acting glucagon‐like peptide‐1 receptor agonists
Description
Grandt AD, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, et al
Trulicity (dulaglutide) Approved - A weekly GLP-1 receptor agonist for managing type 2 diabetes that also supports moderate weight loss by regulating appetite and blood sugar
Jos Luis Grriz has the following financial relationships: advisor on scientific boards for Astra-Zeneca, Bayer and Novo-Nordisk
doi:10.1074/jbc.M303509200 73
